INFO LINE 1300 019 028

Haemochromatosis and Iron Overload Conference

17 & 18 May 2014, Austin Hospital, Heidelberg, Melbourne
Conference website conference.ha.org.au

Newly diagnosed? You may be eligible to participate in the Mi-Iron Research Study

More information here

Haemochromatosis

Haemochromatosis is the most common genetic disorder among people of European descent in Australia. It can cause the body to absorb and store excess iron, often with serious health impacts. The good news is that it is generally easily treated and if diagnosed early, people with haemochromatosis can expect to lead a normal, healthy life. Find out more here: What is haemochromatosis?

Haemochromatosis Australia

Haemochromatosis Australia is the support, advocacy and health promotion group for people affected by haemochromatosis. Our vision is that ‘No Australian should suffer harm from haemochromatosis’. Find out more here: Haemochromatosis Australia

blood_drop_BdG_RGB 72dpi
December 17th, 2013

Survey – Cost of Haemochromatosis

How much does haemochromatosis cost an individual in terms of health costs, productivity and well-being? How much does haemochromatosis cost the Australian health system and society in general? Would you like to help us find the answer?       Researchers at the Menzies Research Institute Tasmania are conducting a study into the costs related […]

November 26th, 2013

Haemochromatosis and Iron Overload Conference 2014

Melbourne 17 & 18 May 2014, Austin Hospital, Heidelberg Website: conference.ha.org.au Flyer – download. Invitation from Ben Marris, President Haemochromatosis Australia On behalf of Haemochromatosis Australia it gives me great pleasure to invite you to the Haemochromatosis and Iron Overload Conference at the Austin Hospital, Melbourne, on 17th and 18th May 2014. We are delighted that […]

CELL-Red-Blood-Cell
November 25th, 2013

Newly diagnosed? You may be eligible to participate in Mi_Iron research study

Approximately 85,000 Australians have or will develop iron overload due to a genetic fault in the HFE gene; however the vast majority of these people will have only moderately elevated levels of iron.

Mi-iron is a research study which aims to measure the effect of reducing moderate iron overload back to the normal range in people with haemochromatosis and to determine whether it is necessary to do this.